Sphingomyelin and ceramide are physiological ligands for human LMIR3/CD300f, inhibiting FcεRI-mediated mast cell activation
about
Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel DiseaseIdentification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor FamilyLipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic TargetsFunctional receptor molecules CD300lf and CD300ld within the CD300 family enable murine noroviruses to infect cellsDisrupting ceramide-CD300f interaction prevents septic peritonitis by stimulating neutrophil recruitment.CD300f:IL-5 cross-talk inhibits adipose tissue eosinophil homing and subsequent IL-4 productionCD300f immunoreceptor contributes to peripheral nerve regeneration by the modulation of macrophage inflammatory phenotype.Histamine Release from Mast Cells and Basophils.Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation.Effect of Specific Mutations in Cd300 Complexes Formation; Potential Implication of Cd300f in Multiple SclerosisThe CD300e molecule in mice is an immune-activating receptor.Human eosinophils and mast cells: Birds of a feather flock together.Leukocyte mono-immunoglobulin-like receptor 8 (LMIR8)/CLM-6 is an FcRγ-coupled receptor selectively expressed in mouse tissue plasmacytoid dendritic cells.
P2860
Q28073700-E8F41913-087F-4B98-A0EF-DF371F27EB35Q28115550-7FE3D15A-C3E9-432F-A6A8-01C84726DAA1Q28276574-0B89204C-22C7-4302-BA6F-6196836EB39BQ28590071-40A2F708-A2B4-4702-B6B8-2F551FF5B6E1Q33842942-5140297A-0E85-4117-B93B-8E6DE45272C6Q33918803-FE315B7C-BF1A-478F-8A15-B0D95F0FDC95Q35936558-A51171A9-1535-4F6C-B241-0CFF931A01ACQ40282553-426F17CF-8A38-4B61-BB39-EEC08F065539Q41882434-6586768D-0A58-44A0-8D3E-BD8560A74AEFQ42659862-F6D968D9-9A71-4314-A90D-3F5E9413D50EQ49874464-66222959-8379-4ED3-ABC6-623EBF0044BAQ50068947-0C1D35B7-C079-4A5C-B25B-EF4FFA0367A2Q55208863-14B856B3-FD26-4D95-8A79-2E17C3C589A0
P2860
Sphingomyelin and ceramide are physiological ligands for human LMIR3/CD300f, inhibiting FcεRI-mediated mast cell activation
description
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artikull shkencor
@sq
artículu científicu espublizáu en 2014
@ast
im Januar 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2014
@uk
مقالة علمية (نشرت عام 2014)
@ar
name
Sphingomyelin and ceramide are ...... -mediated mast cell activation
@ast
Sphingomyelin and ceramide are ...... -mediated mast cell activation
@en
Sphingomyelin and ceramide are ...... -mediated mast cell activation
@nl
type
label
Sphingomyelin and ceramide are ...... -mediated mast cell activation
@ast
Sphingomyelin and ceramide are ...... -mediated mast cell activation
@en
Sphingomyelin and ceramide are ...... -mediated mast cell activation
@nl
prefLabel
Sphingomyelin and ceramide are ...... -mediated mast cell activation
@ast
Sphingomyelin and ceramide are ...... -mediated mast cell activation
@en
Sphingomyelin and ceramide are ...... -mediated mast cell activation
@nl
P2093
P921
P3181
P1476
Sphingomyelin and ceramide are ...... -mediated mast cell activation
@en
P2093
Akie Maehara
Ayako Kaitani
Ko Okumura
Kumi Izawa
Mariko Takahashi
Masamichi Isobe
Shinichi Ito
Toshihiko Oki
Toshihiro Matsukawa
Toshio Kitamura
P304
270–273.e1-7
P3181
P356
10.1016/J.JACI.2013.08.008
P407
P50
P577
2014-01-01T00:00:00Z